Launching Longevitydocs 2.0
#87 Weekly Longevity Medicine Intelligence
Hey Doc,
Three years ago, I started Longevity Docs from a WhatsApp group of dozen physicians. The mission is still the same: to democratize longevity medicine and make sure every doctor has the tools, the knowledge, and the community to practice it.
This week feels like a milestone.
I just got back from Denver, from AAD, the largest dermatology conference in the world. The energy around longevity medicine was impressive. Dermatologists are not just curious anymore. They are ready. They are asking the right questions. They want the knowledge. They want the community. They want in.
The timing could not be better.
Today we are launching Longevity Docs 2.0, our new home for the most influential physician community in longevity medicine. And we are celebrating our first-ever Certified LongevityDoc, Dr. Naana Boakye, a dermatologist who saw this coming before most.
This is just the beginning.
Dr. David Luu - Founder, longevitydocs.™
PS: thank you for your patience … a few days late, I know. Travel has been intense lately. But when I see my son waking up on the deck in the morning sun, I remember exactly what this is all about. That is the type of longevity we are building towards.
Each week, I try to explore one idea that could advance longevity medicine and hopefully support physicians in bringing it to life.
Longevitydocs 2.0: We Built You a Home
In February, we asked you a simple question: what do you actually need? The answers were clear: a searchable forum, shared protocols, a resource library, direct messaging between members. Not a WhatsApp group. A real home.
You asked. We built.
Today we are announcing Longevity Docs 2.0: the evolution of our community from a chat thread into a fully integrated platform built by physicians, for physicians. The most influential community in longevity medicine now has a place where it belongs.
Why We Built This
WhatsApp was never the destination. It was the beginning. A 10-physician became hundreds members across 60+ countries. The conversations got sharper. The protocols got more sophisticated. The community got bigger than any chat app was designed to hold.
Brilliant clinical insights were disappearing into scroll history. Protocols were being shared without documentation. Connections were happening between phone numbers instead of physician profiles. We needed more.
What’s Live Now: Beta by Invitation
The beta is open. Not to everyone yet, intentionally. We started with our earliest members, our most active contributors, and our Certified Longevity Docs candidates. The OGs who showed up when this was still just an idea.
Here is what they are building inside right now.
Chat: Rebuilt from the Ground Up. Every member has a real profile, not a phone number. Every message can be answered as a thread. Every thread can be saved. The conversation you’re having today won’t disappear tomorrow.
Hippo: A learning assistant trained on our certification curriculum. Ask anything about longevity medicine and get an answer grounded in the science we’ve built together. Available to all members. Fully unlocked for CLDs (this is not a Clinical Decision Support)
Intelligence Brief: Daily synthesis of what matters (PubMed, journals, media) filtered through a longevity medicine lens and organized by Research, Clinical, and Business. All intelligence in one place
School. Our masterminds and our Certification program are now directly on the platform. One home for your clinical education.
What’s Coming
We’re building fast and are working on shipping a feature every week. Here’s what’s next
Opportunities: curated hiring and consulting opportunities sourced specifically for longevity physicians.
Practice: tools for solo practitioners and clinics to grow their practice, build membership revenue, and strengthen their community presence.
Patients: a channel for physicians to communicate directly with patients.
The Next Era
The next era of longevity medicine will be collaborative, physician-owned, and science-first. As knowledge and software become commodity, physicians will always find a home in Longevitydocs.
We started with a conversation. Now we have a home.
The beta is live. Your invitation is coming.
Welcome to Longevitydocs 2.0.
Every week, the Longevity Docs WhatsApp group feels like a front-row seat to the future of medicine. Here’s what had doctors buzzing:
PRACTICE
Quest & Labcorp Rate Negotiation
Physicians in the community are actively negotiating better lab rates and sharing real numbers with each other. One member asked for “competitor pricing” after Quest pushed back on her rate request. Several colleagues stepped up to share their own contracts directly.
For longevitydocs: Running a longevity practice means managing margins. Knowing what your peers are paying is leverage. If you haven’t renegotiated your lab rates recently, you’re likely leaving money on the table. Connect with colleagues who have volume-based contracts. The community is your best benchmark.
INTERVENTION
Cord Blood Banking
A member’s daughter is expecting the community’s newest arrival. The conversation quickly turned practical: where to store umbilical cord stem cells. Cryocell came up as the top recommendation, with LifeBank USA flagged as the hospital-affiliated option.
For longevitydocs: Your patients are asking about this. Having a clear, evidence-informed recommendation ready (including what to look for in a storage provider) is a simple way to add value at a pivotal moment in a family’s life.
TECH & AI
AI Scribes & Clinical Documentation Freed AI, Heidi, Nabla, Plaud device. Freed winning on virtual visits, transcripts, and informed consent documentation. Heidi better for summaries and tables. Physical devices losing to apps.
AI & HIPAA. Claude Cowork not HIPAA compliant. Google Workspace and Vertex AI (Gemini) viable if set up correctly. N8N self-hosted on AWS/GCP the cleanest solution for HIPAA-safe automations.
Medical AI Tools for Clinical Decision Support Open Evidence (literature-based, PubMed-grounded) vs. ChatGPT (increasingly restrictive on medical questions) vs. Perplexity Health (strong on newer treatments). Always double check.
Last June, physicians, researchers, and founders from around the wordl gathered in Cannes for two days.
Watched the Mediterranean turn gold from the Majestic Pier. We ran La Croisette at sunrise. Had lunch with speakers on the beach. We left with protocols, partnerships, and friendships that don’t happen at any other event in medicine.
That was year one. This is year two, and it’s not slowing down.
The longevitydocs Summit & Awards is becoming the most important gathering in longevity medicine. Not because of the venue. Because of what happens when the right physicians and partners are together in the same room.
June 9–11. Cannes. You should be there.
Systemic epigenetic dysregulation as a driver of ageing and a therapeutic target
This framework reveals why therapeutics targeting epigenetic systems have consistent effects across multiple model systems and ageing phenotypes. The interconnected organization of chromatin regulation mechanisms creates concrete therapeutic targets to restore regulatory coherence. By providing mechanistic clarity on how epigenetic dysregulation drives ageing phenotypes, we aim to enable rational design of therapeutics that target the epigenetic systems that fail during ageing, rather than individual molecular defects. Nature Reviews
Trial Shows Lower LDL Target Cuts Heart Risks by 33%
Among patients with atherosclerotic cardiovascular disease, targeting an LDL cholesterol level below 55 mg per deciliter led to a lower 3-year risk of cardiovascular events than targeting a level below 70 mg per deciliter. Full Ez-PAVE trial results: NEMJ
Premature Menopause and Lifetime Risk of Coronary Heart Disease
In this cohort study published in JAMA premature menopause was associated with 40% higher lifetime risk of CHD in Black and White women. This suggests that premature onset of menopause is an important risk-enhancing factor for lifetime risk and should be routinely assessed in clinical practice to consider intensification of preventive efforts.
The First. But Not the Last.
Dr. Naana Boakye just made history. Here’s why it matters for every doctor reading this.
In October 2025, Dr. Naana Boakye made a decision that would change the trajectory of her practice. She enrolled in the Certified LongevityDocs program. Six months later, she made history.
Dr. Naana Boakye, MD, CLD, MPH is now the first-ever Certified LongevityDoc in the world.
She did it while running a full dermatology practice. Seeing patients every day. Showing up. That is what commitment looks like.
Why she did it
She didn’t need another credential. She needed a framework.
Like many of us, she saw the gap. Patients weren’t just asking about their skin anymore. They were asking about their energy, their aging, their future. They wanted a doctor who could see the whole picture.
In her own words:
“Patients sit back and they’re just like, no one has talked to me about this before. They’re so empowered. I’m connecting the dots. You’re inflamed now, so we have to do X, Y and Z, and I’ll see you back in three months. And they’re just like, whoa.”
That moment. That is why longevity medicine exists.
What changed for her
Dr. Boakye had been practicing lifestyle medicine for years. But something was missing.
“This just seems like a natural fit. The natural next step.”
The Certified LongevityDocs program gave her the clinical framework to connect the dots. Biomarker diagnostics. Metabolic health. Cellular biology. Regenerative protocols. All of it layered on top of the dermatology expertise she had already spent years building.
For a dermatologist, it is a natural extension. Skin is the most visible organ of aging. The biological mirror of everything happening inside. Dr. Boakye understood that before most.
What the Certified LongevityDocs program is
Not a weekend seminar. Not a marketing badge.
A rigorous, physician-grade certification built for doctors who believe medicine should be proactive, not reactive. That healthspan matters as much as lifespan. That every doctor, regardless of specialty, should be equipped to guide their patients through the science of aging.
Built for practicing physicians. Designed around your schedule. Delivered through our platform alongside a global community of physicians asking the same questions you are.
And when you complete it, you do not just earn a credential. You join a movement.
“There’s definitely a movement going on.” Dr. Boakye said it herself.
The movement
Longevity Docs started as a WhatsApp group of nine physicians in February 2023. Today it is a global community of over 1,000 physicians across 68 countries. All united by one belief.
Every doctor should be a longevity doctor.
The patients in your waiting room are already thinking about their biological age. Their cellular health. Their next 30 years. They are reading the science. They are asking the questions. The only question is whether their doctor is ready to answer them.
Dr. Boakye is ready. She proved that this week.
Your turn
Dr. Boakye started in October. She finished as the first.
The physicians joining the April cohort will be among the first Certified LongevityDocs in the world. They will know each other by name. They will build together. They will look back at this moment as the one where everything changed.
Be part of the longevity medicine movement
Every week, I track funding, FDA approvals, product launches, and breakthrough announcements shaping longevity medicine.
CARE
Data show people racing to chatbots for health advice
A Rock Health survey of 8,000 consumers found 32% had used AI chatbots for health information, twice the number from a year ago. Of those, 56% used them to search for a diagnosis based on symptoms. This was before OpenAI and others launched dedicated health AI products. Your patients are showing up having already consulted a chatbot. That conversation happened before yours. Longevity physicians who integrate AI literacy into patient education - and who lead with precision data rather than general advice - will hold the clinical authority and trust that chatbots cannot replace.
───
AI & TECH
Tom Brady Bets $200M on GLP-1s
eMed closed a $200M Series A at a $2B+ valuation. Brady is Founding Chief Wellness Officer and investor. Linda Yaccarino (ex-X CEO) runs the company. The model is employer-facing. GLP-1s are the most requested workplace benefit, yet only 1 in 5 companies offer it. PR Newswire eMed closes that gap with AI-managed clinical programs. 90% adherence, double the industry norm.
───
WEARABLES
Oura Ring And Symptoms Radar
Symptom Radar could catch serious disease. The feature flags deviations from personal baseline vitals, no diagnosis, just a signal. It has now surfaced multiple cases of lymphoma and appendicitis in users who would have otherwise delayed care. The ring didn’t diagnose anything. It created the nudge to seek one. Condition-specific alerts may be the next frontier for Oura, and the company is already laying the groundwork. Through Oura Labs (in the Oura app), ring owners can opt into a clinical study focused on detecting high blood pressure. CNET
PHARMA/BIOTECH
FDA Approves Higher-Dose Semaglutide (Wegovy HD 7.2mg)
The FDA cleared Wegovy HD in just 54 days under its National Priority Voucher program. Same molecule. Higher dose. With semaglutide patents expiring in India and China and biosimilars incoming, Novo is building branded differentiation before the generic wave hits. Expect patients to ask for it. Have a clear protocol ready: who qualifies for the dose escalation, how you monitor, and how you counsel on the new skin sensitivity signal. Compounding access is already tightening.
Mastermind Replays Now Available
3 Masterminds. 3 topics reshaping longevity practice: AI & Tech, Peptides, and Hormones - featuring the dozens of faculty. Trusted by hundreds of physicians
If you weren’t in the room, this is your second chance.
Conferences
Jun 9–11 — Longevity Docs Cannes 2026”: Awards & Summit
Jun 29–Jul 1 — A4LI H-SPAN Summit · Washington, DC Longevity medicine meets regulation and policy.
Aug 24–28 — ARDD · Copenhagen, Denmark Where aging research meets drug discovery.
Oct 17 — Longevity Docs Skin Longevity Mastermind · New York, NY. Curated physicians. Deep science. One room.
TBA — Longevity Clinics Roundtables · Buck Institute Clinical practice meets research infrastructure.
The Home of Longevity Medicine
longevitydocs.™ is the world’s leading longevity physician community - 600+ doctors across 50 countries united by a single conviction: every doctor should be a longevity doctor. Founded by Dr. David Luu, the platform offers its members network, education, and experience with the mission to democratize longevity medicine.
Not a member yet? Join longevitydocs™
We’re a physician-only network. Curated. Vetted. Built on trust. If you’re committed to practicing longevity medicine with rigor, peer support, and shared standards → this is your community. Apply to connect with our team.
Longevity medicine is the personalized, evidence-based practice of modifying the root mechanisms of aging (biological, cognitive, and psychosocial) before they become disease, extending healthspan, not just lifespan. Using advanced diagnostics, precision interventions, and AI-enabled monitoring, it translates measurement into action across every medical discipline. Success is measured in functional capacity, vitality, and disease-free years.
Subscribe to the Longevity Docs Newsletter
Longevity medicine is moving fast. Every week, we bring you what matters: clinical insights, research signals, and perspectives from 600+ physicians across 50+ countries. One newsletter. Built for the physicians shaping this field.
Editorial Disclaimer:
How can one join the what’s app?